Pharmacological and Therapeutic Potential of Beauvericin: A Short ReviewShivani Sood1*, Sardul Singh Sandhu2 and Tapan Kumar Mukherjee1
- *Corresponding Author:
- Shivani Sood
Department of Biotechnology
MMEC, Maharishi Markandeshwar University
Mullana, Ambala, Haryana, India
Tel: 01731 304 400
E-mail: [email protected]mail.com
Received Date: January 07, 2017; Accepted Date: January 27, 2017; Published Date: January 30, 2017
Citation: Sood S, Sandhu SS, Mukherjee TK (2017) Pharmacological and Therapeutic Potential of Beauvericin: A Short Review. J Proteomics Bioinform 10:18-23. doi: 10.4172/jpb.1000421
Copyright: © 2017 Sood S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
An entomopathogenic fungus, Beauveria spp. has been known to have numerous pharmacological and therapeutic implications, especially, in terms of human health making it a suitable for ethnopharmacological use. Beauvericin is a cyclic hexadepsipeptide mycotoxin, a novel bio-metabolite derived from this fungus, exhibiting a very potent anticancer, cytotoxic activities, antiplatelet aggregation and antimicrobial activities. The current review discusses the therapeutic potential of beauvericin including pharmacological and biological activities which will certainly draw the attention of scientific community to improve the production of beauvericin for its use in medical fields.